Prostate cancer radiation study seeks to Fine-Tune treatment by analyzing Tumors' inner workings
NCT ID NCT06200974
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how a type of radiation called HDR brachytherapy changes prostate cancer on a molecular level. Researchers will analyze blood, tissue, and gut bacteria samples from 100 men with low-risk or early intermediate-risk prostate cancer. The goal is to find the best radiation dose by tracking how tumors respond at the cellular level.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
British Columbia Cancer Center for the Southern Interior
RECRUITINGKelowna, British Columbia, V1Y 5L3, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single small incision preserve sexual function after prostate cancer surgery?
- Freezing or heating prostate tumors: a targeted alternative to surgery?
- Targeted radiation plus hormone therapy may slow Low-Volume prostate cancer spread
- Intermittent fasting tested to ease radiation side effects in cancer patients
- Zapping prostate tumors with extra precision: new trial aims for fewer side effects
- Prostate cancer radiation in one day? new study tests faster treatment